STAG2 and acute myeloid leukemia: Thus, this study aimed to analyze the STAG2 protein expression profile in MDS patients, its association with karyotypes, evolution to AML, and its potential as a prognosis biomarker.<h4>Methods</h4>STAG2 expression was analyzed by immunohistochemistry in bone marrow biopsies from 97 MDS patients (24 pediatric, 73 adult) and 20 controls (10 pediatric, 10 adult).